Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Nielsen

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Addiction (Abingdon, England)|December 28, 2019
Commentary on Cairns et al. (2020): Codeine rescheduling-where to from here?Suzanne Nielsen
Current Topics in Behavioral Neurosciences|December 24, 2015
BenzodiazepinesSuzanne Nielsen
Journal of Agricultural and Food Chemistry|October 17, 2002
Plasmin system and microbial proteases in milk: characteristics, roles, and relationshipS Suzanne Nielsen
Drug and Alcohol Review|May 7, 2011
Pharmaceutical drugs: the delicate balance between reducing pain and reducing harmSuzanne Nielsen, Raimondo Bruno
Addiction (Abingdon, England)|May 28, 2009
The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommendedSuzanne Nielsen, Nicholas Lintzeris
Australian Prescriber|April 29, 2021
Naloxone for opioid toxicity and overdose in the communityMarianne Jauncey, Suzanne Nielsen
Drug and Alcohol Review|September 25, 2022
The emerging issue of Kamini: A new source of opioid dependenceChris Tremonti, Suzanne Nielsen
Drug and Alcohol Review|January 10, 2020
Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?Shalini Arunogiri, Suzanne Nielsen
The International Journal on Drug Policy|December 15, 2020
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in AustraliaSuzanne Nielsen, Anna Olsen
The International Journal on Drug Policy|September 23, 2022
Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001-2021Amanda Roxburgh, Suzanne Nielsen
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Addiction (Abingdon, England)|December 28, 2019
Commentary on Cairns et al. (2020): Codeine rescheduling-where to from here?Suzanne Nielsen
Current Topics in Behavioral Neurosciences|December 24, 2015
BenzodiazepinesSuzanne Nielsen
Journal of Agricultural and Food Chemistry|October 17, 2002
Plasmin system and microbial proteases in milk: characteristics, roles, and relationshipS Suzanne Nielsen
Drug and Alcohol Review|May 7, 2011
Pharmaceutical drugs: the delicate balance between reducing pain and reducing harmSuzanne Nielsen, Raimondo Bruno
Addiction (Abingdon, England)|May 28, 2009
The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommendedSuzanne Nielsen, Nicholas Lintzeris
Australian Prescriber|April 29, 2021
Naloxone for opioid toxicity and overdose in the communityMarianne Jauncey, Suzanne Nielsen
Drug and Alcohol Review|September 25, 2022
The emerging issue of Kamini: A new source of opioid dependenceChris Tremonti, Suzanne Nielsen
Drug and Alcohol Review|January 10, 2020
Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?Shalini Arunogiri, Suzanne Nielsen
The International Journal on Drug Policy|December 15, 2020
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in AustraliaSuzanne Nielsen, Anna Olsen
The International Journal on Drug Policy|September 23, 2022
Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001-2021Amanda Roxburgh, Suzanne Nielsen
Pageof 29